Translational oncology · 2026
Dissecting immunosuppressive microenvironment in chemotherapy-resistant colorectal cancer through single-cell transcriptomic analysis.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xi Jinchuan, Li Zhihan, Liu Youqiang, Niu Wenbo, Yu Bin, Li Zheng, Wang Guiying
Аннотация
BACKGROUND: Colorectal cancer (CRC) remains a leading cause of cancer-related mortality, with chemotherapy resistance representing a critical barrier to effective treatment. The tumor microenvironment (TME) plays a pivotal role in mediating resistance through complex immunosuppressive mechanisms that remain incompletely understood at cellular resolution.
METHODS: We performed comprehensive single-cell RNA sequencing analysis on 13,380 cells from chemotherapy-sensitive and resistant CRC specimens. Following rigorous quality control and dimensional reduction, we conducted unsupervised clustering, cell type annotation, differential expression analysis, functional enrichment assessment, trajectory inference, and cell-cell interaction network reconstruction. In vitro validation was performed using chemotherapy-resistant cell lines (HCT116-OxR and SW480-5FUR) with quantitative RT-PCR and ELISA assays.
RESULTS: Single-cell analysis revealed profound TME remodeling in resistant tumors characterized by: (1) significant compositional shifts with reduced cytotoxic T cell and NK cell populations and increased regulatory T cells and M2-polarized macrophages; (2) systematic suppression of T cell activation pathways (normalized enrichment score = -2.8, FDR < 0.001) with concurrent upregulation of immunosuppressive programs including hypoxia response, angiogenesis, and metabolic adaptation; (3) enhanced inhibitory cell-cell communication networks featuring elevated PD-L1/PD-1, CTLA-4, TGF-β, and IL-10 signaling; (4) progressive T cell trajectory transitions from cytotoxic effector to exhausted phenotypes; (5) coordinated upregulation of immune checkpoint molecules (PD-L1, TIM-3, LAG-3), inhibitory cytokines (TGF-β1, IL-10), and metabolic enzymes (IDO1, ARG1). In vitro validation confirmed that resistant cell lines exhibited 2.3-5.1-fold transcriptional upregulation and significantly enhanced secretion of immunosuppressive factors (PD-L1, TGF-β1, IDO1, IL-10; all p < 0.001).
CONCLUSIONS: This comprehensive single-cell atlas reveals the multi-dimensional immunosuppressive landscape of chemotherapy-resistant CRC, identifying coordinated cellular, molecular, and spatial mechanisms driving immune evasion. Our findings provide candidate biomarkers for predicting treatment resistance and highlight therapeutic vulnerabilities for developing immunotherapy-based combination strategies to overcome chemotherapy resistance in CRC.
METHODS: We performed comprehensive single-cell RNA sequencing analysis on 13,380 cells from chemotherapy-sensitive and resistant CRC specimens. Following rigorous quality control and dimensional reduction, we conducted unsupervised clustering, cell type annotation, differential expression analysis, functional enrichment assessment, trajectory inference, and cell-cell interaction network reconstruction. In vitro validation was performed using chemotherapy-resistant cell lines (HCT116-OxR and SW480-5FUR) with quantitative RT-PCR and ELISA assays.
RESULTS: Single-cell analysis revealed profound TME remodeling in resistant tumors characterized by: (1) significant compositional shifts with reduced cytotoxic T cell and NK cell populations and increased regulatory T cells and M2-polarized macrophages; (2) systematic suppression of T cell activation pathways (normalized enrichment score = -2.8, FDR < 0.001) with concurrent upregulation of immunosuppressive programs including hypoxia response, angiogenesis, and metabolic adaptation; (3) enhanced inhibitory cell-cell communication networks featuring elevated PD-L1/PD-1, CTLA-4, TGF-β, and IL-10 signaling; (4) progressive T cell trajectory transitions from cytotoxic effector to exhausted phenotypes; (5) coordinated upregulation of immune checkpoint molecules (PD-L1, TIM-3, LAG-3), inhibitory cytokines (TGF-β1, IL-10), and metabolic enzymes (IDO1, ARG1). In vitro validation confirmed that resistant cell lines exhibited 2.3-5.1-fold transcriptional upregulation and significantly enhanced secretion of immunosuppressive factors (PD-L1, TGF-β1, IDO1, IL-10; all p < 0.001).
CONCLUSIONS: This comprehensive single-cell atlas reveals the multi-dimensional immunosuppressive landscape of chemotherapy-resistant CRC, identifying coordinated cellular, molecular, and spatial mechanisms driving immune evasion. Our findings provide candidate biomarkers for predicting treatment resistance and highlight therapeutic vulnerabilities for developing immunotherapy-based combination strategies to overcome chemotherapy resistance in CRC.